Erythromycin

Clinical Trials Overview

1 trials found
About Erythromycin

Erythromycin is not used in the treatment of colorectal cancer (CRC). It is primarily an antibiotic indicated for bacterial infections. There are no clinical trials or indications supporting its use in CRC therapy.

Category Other Medications
Brand Name ** E-Mycin, Ery-Tab, Erythrocin, PCE (as an antibiotic); not marketed for cancer treatment **
Mechanism Erythromycin is a macrolide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, thereby preventing peptide chain elongation.
1
Total Trials
0
Recruiting
0
Active
1
Completed
122
Total Enrollment
1
Countries
Optimization of the Bowel Preparation Regimen for the PillCam® COLON 2 Capsule Endoscopy Procedure
NCT02481219 Not Applicable Completed 122 patients
Start: May 2015
End: Feb 2016
INTERVENTIONAL
Medications: Bisacodyl Erythromycin Gastrografin Metoclopramide Peg Senna
This study is designed to determine the optimal bowel preparation regimen for PillCam® COLON 2 Capsule Endoscopy System (CCE) procedures in average risk patients. Patients will be randomized to receive one of two bowel preparation regimens prior to...
United States
View Details ClinicalTrials.gov Am I eligible?
Back to Drug Glossary View All Trials